We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Recalls Hypertension Drug Produced at Novartis’ Nebraska Plant
GSK Recalls Hypertension Drug Produced at Novartis’ Nebraska Plant
March 1, 2012
GlaxoSmithKline has recalled 10 lots — some 394,000 bottles — of its hypertension drug DynaCirc CR after quality and commingling issues at Novartis’ troubled Lincoln, Neb., plant, where it was produced.